Impact of Herpes Simplex Virus Type 2 and Human Immunodeficiency Virus Dual Infection on Female Genital Tract Mucosal Immunity and the Vaginal Microbiome

Marla J. Keller,Ashley Huber,Lilia Espinoza,Myrna G. Serrano,Hardik Parikh,Gregory A. Buck,Jeremy A. Gold,Yiqun Wu,Tao Wang,Betsy C. Herold
DOI: https://doi.org/10.1093/infdis/jiz203
2019-01-01
Abstract:Background. Mechanisms linking herpes simplex virus type 2 (HSV-2) with human immunodeficiency virus (HIV) are not fully defined. We tested the hypothesis that HSV-2 and HIV dual infection is associated with cervicovaginal inflammation and/or vaginal dysbiosis. Methods. Genital tract samples were obtained weekly over a 12-week period from 30 women seropositive (+) for HIV and HSV-2 and 15 women each who were seropositive for one or seronegative (-) for both viruses. Immune mediators, antimicrobial activity, and microbial composition and diversity were compared. Results. Significant differences in the concentrations of interferon-gamma (P =.002), tumor necrosis factor-a (P =.03), human beta defensin 1 (P =.001), secretory leukocyte protease inhibitor (P =.01), and lysozyme (P =.03) were observed across the 4 groups (Kruskal-Wallis). There were also significant differences in vaginal microbial alpha diversity (Simpson index) (P =.0046). Specifically, when comparing HIV-1(+)/HSV-2(+) to HIV-1(-)/HSV-2(-) women, a decrease in Lactobacillus crispatus and increase in diverse anaerobes was observed. The number of genital HSV outbreaks was greater in HIV+ versus HIV- women (39 versus 12) (P =.04), but there were no significant differences when comparing outbreak to non-outbreak visits. Conclusions. Increased microbial diversity and cervicovaginal inflammation in HIV and HSV-2 dually infected women may adversely impact genital health and, in the absence of antiretroviral therapy, facilitate HIV shedding.
What problem does this paper attempt to address?